INHIBITION OF CYP1A, CYP2B, AND CYP3A ACTIVITIES BY 5HT3 ANTAGONISTS

被引：0

作者：

GAN, LS ^{[1
]}

BOEHLERT, C ^{[1
]}

THAKKER, D ^{[1
]}

SERABJITSINGH, C ^{[1
]}

机构：

[1] GLAXO RES INST,DEPT DRUG METAB,RES TRIANGLE PK,NC 27709

来源：

FASEB JOURNAL | 1994年 / 8卷 / 07期

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：A1248 / A1248

页数：1

共 50 条

[41] DISSECTING CYP3A INTERACTOME TO UNDERSTAND THE CAUSES OF CYP3A VARIABILITY [J].

Wang, Danxin ;

Lu, Rong ;

Rempala, Grzegorza ;

Sadee, Wolfgang .

DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) :S83-S84

[42] Pronounced induction of CYP4A, CYP2B and CYP3A activity in rats treated with the RXR agonists RWJ-392063 and RWJ-666589 [J].

Krueger, Linda A. ;

McMullen, Maggie ;

Parkinson, Andrew ;

Stahle, Paul ;

Streeter, Anthony J. .

DRUG METABOLISM REVIEWS, 2006, 38 :107-107

[43] Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes [J].

Drocourt, L ;

Pascussi, JM ;

Assenat, E ;

Fabre, JM ;

Maurel, P ;

Vilarem, MJ .

DRUG METABOLISM AND DISPOSITION, 2001, 29 (10) :1325-1331

[44] COMPARISON OF CYTOCHROME-P450 IN 3 BUTTERFLYFISH SPECIES - ECOLOGICAL IMPLICATIONS OF ELEVATED CYP2B AND CYP3A IN CHAETODON-CAPISTRATUS [J].

VROLIJK, NH ;

TARGETT, NM ;

WOODIN, BR ;

STEGEMAN, JJ .

MARINE ENVIRONMENTAL RESEARCH, 1995, 39 (1-4) :11-14

[45] Influence of CYP3A5 genotype on the extent of CYP3A inhibition in healthy African-Americans [J].

Isoherranen, Nina ;

Paine, Mary F. ;

Givens, Raymond C. ;

Ludington, Shana S. ;

Hawke, Roy L. ;

Pusek, Susan N. ;

Dees, E. Claire ;

Blough, David ;

Iwanaga, Kazunori ;

Watkins, Paul B. ;

Thummel, Kenneth E. .

DRUG METABOLISM REVIEWS, 2006, 38 :89-89

[46] Expression and induction by rifampicin of CAR- and PXR-regulated CYP2B and CYP3A in liver, kidney and airways of pig [J].

Nannelli, Annalisa ;

Chirulli, Vera ;

Longo, Vincenzo ;

Gervasi, P. Giovanni .

TOXICOLOGY, 2008, 252 (1-3) :105-112

[47] Evaluation of Potential Effects of CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Fruquintinib in Healthy Subjects [J].

Gonzalez, Martha ;

Yang, Zhao ;

Schelman, William R. ;

Zhou, Xiaofei ;

Gupta, Neeraj ;

Chien, Caly .

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2025,

[48] Negative regulation by dexamethasone of fluvastatin-inducible CYP2B expression in primary cultures of rat hepatocytes: Role of CYP3A [J].

Kocarek, TA ;

Reddy, AB .

BIOCHEMICAL PHARMACOLOGY, 1998, 55 (09) :1435-1443

[49] GABAA/central benzodiazepine receptor and peripheral benzodiazepine receptor ligands as inducers of phenobarbital-inducible CYP2B and CYP3A [J].

Roberge, C ;

Beaudet, MJ ;

Anderson, A .

BIOCHEMICAL PHARMACOLOGY, 2004, 68 (07) :1383-1389

[50] Insulin differentially affects xenobiotic-enhanced, cytochrome P-450 (CYP)2E1, CYP2B, CYP3A, and CYP4A expression in primary cultured rat hepatocytes [J].

Woodcroft, KJ ;

Novak, RF .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 289 (02) :1121-1127

← 1 2 3 4 5 →